Thread: Tysabri Talk
View Single Post
Old 12-14-2006, 08:51 PM
SallyC's Avatar
SallyC SallyC is offline
In Remembrance
  
Join Date: Sep 2006
Location: SW Ohio
Posts: 17,844
15 yr Member
SallyC SallyC is offline
In Remembrance
SallyC's Avatar
 
Join Date: Sep 2006
Location: SW Ohio
Posts: 17,844
15 yr Member
Default
Quote:
Originally Posted by lady_express_44 View Post
I have a hard copy of the BMJ article, but can't access it on their website because you need a membership to do so.

The article was called "Lessons for clinical trials from natalizumab in multiple sclerosis", written by Abhijit Chaundhuri:

http://www.bmj.com/cgi/content/citation/332/7538/416

The hard copy reads "On 18 February 2005, 10 days before the public announcement, the FDA received information from Biogen Idec of one confirmed death and one possible case of progressive multifocal leucoencephalopathy in patients receiving natalizumab for Multiple Sclerosis".

Cherie
Well that happened too, but that's not what I'm talking about. A Trial Doc informed Biogen of PML being a factor on the 9th of Feb, if I recall it correctly.

Damn I wish I could find it.
__________________
~Love, Sally
.





"The best way out is always through". Robert Frost



~If The World Didn't Suck, We Would All Fall Off~
SallyC is offline   Reply With QuoteReply With Quote